ipriflavone has been researched along with Spinal Diseases in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Spinal Diseases: Diseases involving the SPINE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agnusdei, D | 1 |
| Crepaldi, G | 1 |
| Isaia, G | 1 |
| Mazzuoli, G | 1 |
| Ortolani, S | 1 |
| Passeri, M | 1 |
| Bufalino, L | 1 |
| Gennari, C | 1 |
1 trial available for ipriflavone and Spinal Diseases
| Article | Year |
|---|---|
A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss.
Topics: Aged; Bone Remodeling; Double-Blind Method; Female; Humans; Isoflavones; Middle Aged; Osteoporosis, | 1997 |